Get notified when GWLL files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Going Concern (worsened) — Going concern language persists; working capital deteriorated from positive $190,055 to negative $(361,319), cash declined from $17,127 to $13,414, and inventory of $174,788 vanished — financial position materially worsened.
OTC: GWLL GOLDENWELL BIOTECH, INC. 10-Q

Working capital swings negative as $175K inventory expires; $100K related-party advance booked

Filed July 1, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 27, 2025 · ~1 min read

Key Changes

  • high

    Working capital deteriorated from positive $190,055 to negative $(361,319) as entire inventory ($174,745) expired in January 2026 and was fully written down; cash declined 22% to $13,414.

    MD&A: Liquidity & Notes: Inventory Impairment verify on EDGAR →
  • high

    Company received $100,000 from Trefoil (Hong Kong) under a technical development arrangement; CEO Shuang Liu serves as CEO of both entities, creating a related-party transaction.

    Notes: Related-Party Transactions view on EDGAR →
  • high

    Current liabilities surged 53-fold from $1,860 to $100,000 (unearned revenue), while total liabilities rose 39% to $380,073; stockholders' equity deficit widened to $(361,319).

    MD&A: Balance Sheet verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (FDS 10-Q) is open in full — no account needed.

Partner

Trade GWLL commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jul 7, 2026 · How we verify